… may be potential biomarkers and therapeutic targets for AKI. In … promising biomarkers and
potential therapeutic targets for AKI, … as therapeutic targets for kidney diseases, including AKI. …

… (HIF-PH), they have been a good therapeutic target to stabilize HIF. HIF-PH are nonheme …
Cobalt, a chelator of iron, has been reported to improve kidney injury in several CKD animal …

… Acute kidney injury (AKI) has become a global public health … for identifying potential therapeutic
targets. Macrophage‑sensing … identification of novel therapeutic targets for this condition. …

… clinical use may induced acute kidney injury and nephrotic syndrome. … therapeutic targets
in kidney injury, as demonstrated for some of them. However, the role of most MAP3K in kidney …

… kidney lesions in some conditions and situations [30, 31]. For activation of autophagy to serve
as a therapeutic target in … protects or avoids harming the kidneys in a myriad of situations. …

… Acute kidney injury (AKI) is a major renal disease associated … for reducing kidney tissue
damage and promoting kidney repair … of combination therapy by targeting multiple targets in AKI. …

… knowledge gaps and potential new therapeutic targets of human AKI [11,12,13,14]. As
described by Basile et al., the initiation phase of kidney injury is marked by energetic failure and …

… The connections between cellular stress responses and maladaptive repair mechanisms
are biologically complex and rich with therapeutic targets, where an impact on one can affect …

… Expert opinion: CD133 could be of interest as a possible therapeutic target for nonmalignant
renal pathology. Selective targeting of CD133 may allow pharmacological approaches to …

… the exact mode of Smad4 in kidney disease remains unclear, the diverse roles for Smad4 in
renal fibrosis and inflammation suggest that Smad4 may not be a therapeutic target for CKD. …